Paul Ryan and Ron Wyden have defined the policy parameters that could be the basis for real Medicare reform in 2013.

This return to two-party government creates a tougher political climate for the White House in implementing health care reform.

The Obama plan offers a host of policy proposals that, in the main, address the symptoms but not the underlying disease that afflicts the health care system.

Appropriate off-label use of drugs that informs proper patient care is fostered by more communication of truthful information.

In a just released piece in the New England Journal of Medicine piece, American Enterprise Institute (AEI) healthcare economist and former Congressional Budget Office official Joseph Antos assesses the Wyden-Ryan Medicare reform proposal.

Last June, New York State Attorney General Eliot Spitzer sued the maker of an antidepressant for withholding unfavorable information about the safety and effectiveness of a drug. The suit, filed in the New York Supreme Court and settled this summer, claimed that GlaxoSmithKline conducted at least five studies on the...

This week, the New England Journal of Medicine reported the results of a remarkable study on an experimental drug that dramatically improved treatment of blacks with heart disease. BiDil is now on course to become the first "Race Drug"––a prospect fanning debate among the public, scientists, and government officials responsible...

I was initially assigned the working title, "Pursuing Equality in Health Care for the Elderly Is Futile." I prefer to think of that particular dead end of health policy as one of listening to the wrong music for too long. Hence, this article revises the title song of the movie, Urban Cowboy, to "Looking for better health [rather than either "love" or "love of equality"] in all the wrong places.